Wells Fargo & Company Has Lowered Expectations for bluebird bio (NASDAQ:BLUE) Stock Price
bluebird bio (NASDAQ:BLUE – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $40.00 to $5.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biotechnology company’s stock. Wells Fargo & Company‘s price target would suggest a potential […]
bluebird bio (NASDAQ:BLUE – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $40.00 to $5.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biotechnology company’s stock. Wells Fargo & Company‘s price target would suggest a potential […]
